Clearmind Medicine Inc. Stock Analysis & AI Score
Clearmind Medicine Inc. (CMND) has an ST Score of 35.4 (C-), driven by its Growth (A+) and held back by its Momentum (D). CMND last traded at $0.81.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Clearmind Medicine Inc. (CMND) has an ST Score of 35.4 (C-), driven by its Growth (A+) and held back by its Momentum (D). CMND last traded at $0.81.
- Strongest
- GrowthA+
- Weakest
- MomentumD
All factor grades
- GrowthA+
- ValuationC
- ProfitabilityC-
- Financial StrengthD+
- MomentumD
- Piotroski1/9
Contact
CMND stock: frequently asked questions
What is CMND's ST Score?
Clearmind Medicine Inc. (CMND) has an ST Score of 35.4 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CMND a buy, hold, or sell?
Our ST Score grades it C- (35.4/100). The ST Score is a data-driven signal, not a recommendation.
What are CMND's factor grades?
Valuation C, Profitability C-, Financial Strength D+, Momentum D, Growth A+.
What is CMND's valuation grade?
Clearmind Medicine Inc. (CMND) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CMND's growth grade?
Clearmind Medicine Inc. (CMND) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CMND's profitability grade?
Clearmind Medicine Inc. (CMND) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CMND's financial strength grade?
Clearmind Medicine Inc. (CMND) earns a financial strength grade of D+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is CMND's Piotroski score?
Clearmind Medicine Inc. (CMND) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.